181 related articles for article (PubMed ID: 32144855)
1. Mitotic entry upon Topo II catalytic inhibition is controlled by Chk1 and Plk1.
Arroyo M; Cañuelo A; Calahorra J; Hastert FD; Sánchez A; Clarke DJ; Marchal JA
FEBS J; 2020 Nov; 287(22):4933-4951. PubMed ID: 32144855
[TBL] [Abstract][Full Text] [Related]
2. MCPH1 Lack of Function Enhances Mitotic Cell Sensitivity Caused by Catalytic Inhibitors of Topo II.
Arroyo M; Sánchez A; Cañuelo A; Heredia-Molina RF; Martínez-Molina E; Clarke DJ; Marchal JA
Genes (Basel); 2020 Apr; 11(4):. PubMed ID: 32276518
[TBL] [Abstract][Full Text] [Related]
3. Revised genetic requirements for the decatenation G2 checkpoint: the role of ATM.
Bower JJ; Zhou Y; Zhou T; Simpson DA; Arlander SJ; Paules RS; Cordeiro-Stone M; Kaufmann WK
Cell Cycle; 2010 Apr; 9(8):1617-28. PubMed ID: 20372057
[TBL] [Abstract][Full Text] [Related]
4. A PIM-CHK1 signaling pathway regulates PLK1 phosphorylation and function during mitosis.
Adam K; Cartel M; Lambert M; David L; Yuan L; Besson A; Mayeux P; Manenti S; Didier C
J Cell Sci; 2018 Aug; 131(15):. PubMed ID: 29976560
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the topoisomerase II-dependent decatenation G2 checkpoint and checkpoint kinases in human cells.
Kaufmann WK
Methods Mol Biol; 2009; 582():155-66. PubMed ID: 19763949
[TBL] [Abstract][Full Text] [Related]
6. Mitotic DNA damage response: Polo-like kinase-1 is dephosphorylated through ATM-Chk1 pathway.
Lee HJ; Hwang HI; Jang YJ
Cell Cycle; 2010 Jun; 9(12):2389-98. PubMed ID: 20581453
[TBL] [Abstract][Full Text] [Related]
7. MCPH1 is essential for cellular adaptation to the G
Arroyo M; Kuriyama R; Guerrero I; Keifenheim D; Cañuelo A; Calahorra J; Sánchez A; Clarke DJ; Marchal JA
FASEB J; 2019 Jul; 33(7):8363-8374. PubMed ID: 30964711
[TBL] [Abstract][Full Text] [Related]
8. FRET-Based Sorting of Live Cells Reveals Shifted Balance between PLK1 and CDK1 Activities During Checkpoint Recovery.
Lafranchi L; Müllers E; Rutishauser D; Lindqvist A
Cells; 2020 Sep; 9(9):. PubMed ID: 32961751
[TBL] [Abstract][Full Text] [Related]
9. ATR enforces the topoisomerase II-dependent G2 checkpoint through inhibition of Plk1 kinase.
Deming PB; Flores KG; Downes CS; Paules RS; Kaufmann WK
J Biol Chem; 2002 Sep; 277(39):36832-8. PubMed ID: 12147700
[TBL] [Abstract][Full Text] [Related]
10. NFBD1/MDC1 is phosphorylated by PLK1 and controls G2/M transition through the regulation of a TOPOIIα-mediated decatenation checkpoint.
Ando K; Ozaki T; Hirota T; Nakagawara A
PLoS One; 2013; 8(12):e82744. PubMed ID: 24349352
[TBL] [Abstract][Full Text] [Related]
11. Polo-like kinase 1 activated by the hepatitis B virus X protein attenuates both the DNA damage checkpoint and DNA repair resulting in partial polyploidy.
Studach L; Wang WH; Weber G; Tang J; Hullinger RL; Malbrue R; Liu X; Andrisani O
J Biol Chem; 2010 Sep; 285(39):30282-93. PubMed ID: 20624918
[TBL] [Abstract][Full Text] [Related]
12. DNA Replication Determines Timing of Mitosis by Restricting CDK1 and PLK1 Activation.
Lemmens B; Hegarat N; Akopyan K; Sala-Gaston J; Bartek J; Hochegger H; Lindqvist A
Mol Cell; 2018 Jul; 71(1):117-128.e3. PubMed ID: 30008317
[TBL] [Abstract][Full Text] [Related]
13. Selective killing of G2 decatenation checkpoint defective colon cancer cells by catalytic topoisomerase II inhibitor.
Jain CK; Roychoudhury S; Majumder HK
Biochim Biophys Acta; 2015 May; 1853(5):1195-204. PubMed ID: 25746763
[TBL] [Abstract][Full Text] [Related]
14. Centromere fragmentation is a common mitotic defect of S and G2 checkpoint override.
Beeharry N; Rattner JB; Caviston JP; Yen T
Cell Cycle; 2013 May; 12(10):1588-97. PubMed ID: 23624842
[TBL] [Abstract][Full Text] [Related]
15. Differential properties of mitosis-associated events following CHK1 and WEE1 inhibitor treatments in human tongue carcinoma cells.
Nojima H; Homma H; Onozato Y; Kaida A; Harada H; Miura M
Exp Cell Res; 2020 Jan; 386(2):111720. PubMed ID: 31738907
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of Plk1 at S137 and T210 is inhibited in response to DNA damage.
Tsvetkov L; Stern DF
Cell Cycle; 2005 Jan; 4(1):166-71. PubMed ID: 15611664
[TBL] [Abstract][Full Text] [Related]
17. Influence of chk1 and plk1 silencing on radiation- or cisplatin-induced cytotoxicity in human malignant cells.
Gao Q; Huang X; Tang D; Cao Y; Chen G; Lu Y; Zhuang L; Wang S; Xu G; Zhou J; Ma D
Apoptosis; 2006 Oct; 11(10):1789-800. PubMed ID: 16927022
[TBL] [Abstract][Full Text] [Related]
18. Sterigmatocystin-induced checkpoint adaptation depends on Chk1 in immortalized human gastric epithelial cells in vitro.
Jiang X; Wang J; Xing L; Shen H; Lian W; Yi L; Zhang D; Yang H; Liu J; Zhang X
Arch Toxicol; 2017 Jan; 91(1):259-270. PubMed ID: 26914363
[TBL] [Abstract][Full Text] [Related]
19. Checkpoint kinase 1 (Chk1) is required for mitotic progression through negative regulation of polo-like kinase 1 (Plk1).
Tang J; Erikson RL; Liu X
Proc Natl Acad Sci U S A; 2006 Aug; 103(32):11964-9. PubMed ID: 16873548
[TBL] [Abstract][Full Text] [Related]
20. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional.
Lossaint G; Besnard E; Fisher D; Piette J; Dulić V
Oncogene; 2011 Oct; 30(41):4261-74. PubMed ID: 21532626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
